The prognostic significance of bone marrow cytogenetic lesions in myelofibrosis with
myeloid metaplasia (MMM) was investigated in a retrospective series of 165 patients. An …

Among 826 patients with primary myelofibrosis (PMF) and analysable metaphases on
cytogenetic studies, 352 (42· 6%) had abnormal karyotype, of which 240 (68· 2%) were sole …

Abstract BACKGROUND Approximately 30–50% of patients with myelofibrosis with myeloid
metaplasia (MMM) demonstrate detectable cytogenetic abnormalities, the prognostic value …

The dependence of survival time on a set of prognostic factors was explored by means of
Cox's regression model in 137 cases of myelofibrosis with myeloid metaplasia (MMM). The …

The prognostic significance of cytogenetic abnormalities was determined in 106 patients
with well‐characterized idiopathic myelofibrosis who were successfully karyotyped at …

Among 2333 consecutive patients with myelofibrosis with myeloid metaplasia (MMM) seen
at our institution, 91 fulfilled the World Health Organization (WHO) criteria for leukemic …

The prognostic value of 12 clinical and haematological parameters, recorded at diagnosis,
in myelofibrosis with myeloid metaplasia (MMM) was retrospectively analysed in a …

Myelofibrosis with myeloid metaplasia (MMM) is an uncommon disorder in young
individuals, for whom haemopoietic stem cell transplantation offers the only possibility of …

Although cytogenetic abnormalities are important prognostic factors in myeloid
malignancies, they are not included in current prognostic scores for primary myelofibrosis …

We have previously identified sole+ 9, 13q-or 20q-, as 'favorable'and sole+ 8 or complex
karyotype as 'unfavorable'cytogenetic abnormalities in primary myelofibrosis (PMF). In this …